DataM Intelligence announces the latest insights into the rapidly transforming Oncology Molecular Diagnostics Market, which ...

The "Molecular Diagnostics for Cancer – Markets, Strategies and Trends. Forecasts by Cancer Type, Including Companion Dx and by Country with Executive and Consultant Guides and COVID-19 Pandemic ...

Molecular diagnostics is becoming a driving force in drug development. Applications have spread from identifying infections to include screening for cancer, hepatitis, and a variety of genetic ...

Nanopath, a point-of-care diagnostics company enabling high-quality molecular testing in minutes, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device ...

Clinical Utility of Pharmacogenomics and Genetic Testing Remains an Issue Through rapid advances in research and clinical applications, molecular diagnostics has grown from a genomic and proteomic ...

After years as a surgeon, Dr. Lishan Aklog now leads Lucid Diagnostics, a subsidiary of Pavmed, as it advances its unique ...

MEMPHIS, Tenn.--(BUSINESS WIRE)--Spesana, the developer of a novel electronic operating system to unify EMRs, and Biodesix Inc. (NSDQ: BDSX), a leading data-driven diagnostic solutions company with a ...

Insight Molecular Diagnostics Inc. is rated Hold due to upcoming catalysts & pending FDA submission for GraftAssureDx. Read ...